Diadem S.p.A. – Trademark Portfolio

Entity Type: 09

Diadem S.p.A. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 4 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include AZ 284, ALZOSURE, and AZ 292-KK.

Via Ceresio 7

I-20154 Milan

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

AZ 284
AZ 284
Registered 2021
AZ 292-KK
AZ 292-KK
Registered 2021
ALZOSURE
ALZOSURE
Registered 2020
DIADEM
DIADEM
Abandoned 2020

Trademark Classifications

Diadem S.p.A.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (4 filings)

Surgical, medical, dental and veterinary apparatus and instruments

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does Diadem S.p.A. have?

Diadem S.p.A. has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned.

What trademark classes does Diadem S.p.A. file in?

Diadem S.p.A. files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 44 (Medical Services). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Diadem S.p.A.'s most well-known trademarks?

Diadem S.p.A.'s registered trademark portfolio includes well-known marks such as AZ 284, ALZOSURE, and AZ 292-KK. These are among 3 currently registered trademarks in the portfolio.

What is Diadem S.p.A.'s trademark registration success rate?

Diadem S.p.A. has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.